logo Creation made simple
Beautifully designed
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut convallis tempor orci vitae vehicula. Aliquam in ullamcorper lacus.
Follow & share
Search:
Infallible Pharma | INFOVIR INJECTION
21138
portfolio_page-template-default,single,single-portfolio_page,postid-21138,edgt-core-1.0.1,ajax_fade,page_not_loaded,,hudson-ver-1.8, vertical_menu_with_scroll,smooth_scroll,side_menu_slide_from_right,blog_installed,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

INFOVIR INJECTION

INFOVIR INJECTION


Brand Name : Infovir


Generic Name : Acyclovir Intravenous Infusion IP


Pack Size : Vial + WFI


Dosage Form : Intravenous Infusion


Strength : 250 mg & 500 mg


Therapeutic indications : Acyclovir. is indicated for the treatment of Herpes simplex infections in immunocompromised patients and severe initial genital herpes in the non-immunocompromised.
Acyclovir. is indicated for the prophylaxis of Herpes simplex infections in immunocompromised patients.
Acyclovir. is indicated for the treatment of Varicella zoster infections.
Acyclovir. is indicated for the treatment of herpes encephalitis.
Acyclovir. is indicated for the treatment of Herpes simplex infections in the neonate and infant up to 3 months of age.


Pharmacotherapeutic group : Direct acting antivirals, Nucleosides and nucleotides excl. reverse transcriptase inhibitors


ATC code : J05AB01


Pharmacodynamic properties : Acyclovir is a synthetic purine nucleoside analogue with in vitro and in vivo inhibitory activity against human herpes viruses, including Herpes simplex virus types 1 and 2 and Varicella zoster virus (VZV), Epstein Barr virus (EBV) and Cytomegalovirus (CMV). In cell culture Acyclovir has the greatest antiviral activity against HSV-1, followed (in decreasing order of potency) by HSV-2, VZV, EBV and CMV.

Date

February 18, 2022

Share